Federal award
AMPLYX PHARMACEUTICALS, INC.
W81XWH18C0074
Contract
Obligated and Ceiling
- Obligated (net)
- $2,734,526.00
- Ceiling (potential value, not spending)
- $2,734,526.00
- Current value
- $2,734,526.00
- Gross positive obligations
- $3,488,894.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- AMPLYX PHARMACEUTICALS, INC. · N4A8X52DCND5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- PFIZER INC · MHBQULRMEEJ5
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN92 · R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W81XWH18C0074
- Award type code
- D
- Actions
- 5 · Mar 6, 2018 to Dec 14, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 14, 2022 | FY2023 | P00004 | M | −$754,368.00 | — |
| Apr 19, 2019 | FY2019 | P00003 | D | $0.00 | — |
| Oct 4, 2018 | FY2019 | P00002 | D | $0.00 | — |
| Apr 2, 2018 | FY2018 | P00001 | M | $0.00 | — |
| Mar 6, 2018 | FY2018 | 0 | — | $3,488,894.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.